Wed, November 18, 2009
Tue, November 17, 2009
Mon, November 16, 2009
Sun, November 15, 2009
Fri, November 13, 2009
Thu, November 12, 2009
Wed, November 11, 2009
Tue, November 10, 2009
Mon, November 9, 2009
Fri, November 6, 2009
Thu, November 5, 2009
Wed, November 4, 2009
Tue, November 3, 2009
Mon, November 2, 2009
Sun, November 1, 2009
Fri, October 30, 2009
Thu, October 29, 2009
Wed, October 28, 2009
Tue, October 27, 2009
Mon, October 26, 2009
Sun, October 25, 2009
Fri, October 23, 2009
Thu, October 22, 2009
Wed, October 21, 2009
Tue, October 20, 2009
Mon, October 19, 2009
Fri, October 16, 2009
Thu, October 15, 2009
Wed, October 14, 2009
Tue, October 13, 2009
Mon, October 12, 2009
Fri, October 9, 2009
Thu, October 8, 2009

Syneron Medical to Announce Third Quarter 2009 Financial Results on November 9th, 2009


//health-fitness.news-articles.net/content/2009/ .. 2009-financial-results-on-november-9th-2009.html
Published in Health and Fitness on Thursday, October 29th 2009 at 5:39 GMT by Market Wire   Print publication without navigation


YOKNEAM, ISRAEL--(Marketwire - October 29, 2009) - Syneron Medical Ltd. (NASDAQ: [ ELOS ]), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, today announced that it will release its financial results for the third quarter of 2009 before market opening on Monday, November 9, 2009. The earnings release will be available on Syneron's website at [ www.syneron.com ].

Syneron management will host a conference call and a live webcast at 8:30am (ET) on the same day. A question & answer session will follow management's discussion of events in the third quarter.

Investors and analysts may participate in the conference call on the following dial-in numbers:

US (toll free): 888-211-7360

International: +1-913-312-0959

Investors and other interested parties can also access a live webcast of the conference call through the Investor Overview page on Syneron's website at [ www.syneron.com ]. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the webcast will be available within 24 hours on the Company's website.

About Syneron

Syneron Medical Ltd. (NASDAQ: [ ELOS ]) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron has offices and distributors throughout the world, including North American headquarters in Irvine, CA, and Asia-Pacific headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at [ www.syneron.com ].

Syneron, the Syneron logo, and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical Ltd. All other names are the property of their respective owners.


Publication Contributing Sources